Literature DB >> 9475170

Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop.

M Nycander1, S Estrada, J S Mort, M Abrahamson, I Björk.   

Abstract

Stopped-flow kinetics showed that the inhibition of the lysosomal cysteine proteinase, cathepsin B, by its endogenous inhibitor, cystatin C, occurs by a two-step mechanism, in which an initial, weak interaction is followed by a conformational change. The initial interaction most likely involves binding of the N-terminal region of the inhibitor to the proteinase. Considerable evidence indicates that the subsequent conformational change is due to the inhibitor displacing the occluding loop of the proteinase that partially obscures the active site. The presence of this loop, which allows the enzyme to function as an exopeptidase, thus complicates the inhibition mechanism, rendering cathepsin B much less susceptible than other cysteine proteinases to inhibition by cystatins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475170     DOI: 10.1016/s0014-5793(97)01604-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group.

Authors:  S Estrada; S T Olson; E Raub-Segall; I Björk
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

3.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

4.  Expression, purification, and characterization of human cystatin C monomers and oligomers.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  Protein Expr Purif       Date:  2015-09-25       Impact factor: 1.650

5.  A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

6.  Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.

Authors:  E Pol; I Björk
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

7.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

8.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

9.  Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling.

Authors:  Napoleão F Valadares; Márcia Dellamano; Andrea Soares-Costa; Flávio Henrique-Silva; Richard C Garratt
Journal:  BMC Struct Biol       Date:  2010-09-30

10.  Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects.

Authors:  Meghan E Wilson; Imene Boumaza; Robert Bowser
Journal:  Fluids Barriers CNS       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.